Authors
Latest:
The Relationship Between Epstein-Barr Virus and Multiple SclerosisThe paradigm-shifting evidence of the link between MS and EBV does not exist in isolation. In fact, the relationship has been suspected for more than 40 years, and evidence therein has been accumulating over the past 2 decades.
Latest:
Insights on Migraine, Autonomic Dysfunction, and Stroke Risk from the ARIC Study: Souvik Sen, MD, MPH, FAHAThe chair of neurology at the University of South Carolina discussed findings from a study recently presented at AHS 2025 that linked migraine to autonomic dysfunction, increased risk of atrial fibrillation, and cardioembolic stroke. [WATCH TIME: 5 minutes]
Latest:
Adding Experience to the National Health Institute Council: Amy Brin, MSN, MA, PCNS-BCThe chief executive officer of the Child Neurology Foundation provided insight on her new position at the National Health Institute’s National Advisory Neurological Disorders and Stroke Council. [WATCH TIME: 4 minutes]
Latest:
Clinical Perspective of Insomnia in Sleep MedicineAlexander Scheer, MD, medical director at Scheer Medical Wellness, provided his medical perspective on insomnia in the clinical practice of sleep medicine.
Latest:
Preventing Epilepsy Through Antiseizure Medication in Tuberous Sclerosis Complex: Gabrielle Rushing, PhDThe director of research at the TSC Alliance spoke with us at the 2022 AES Conference about future research to be conducted on patients with TSC such as the PREVeNT trial. [WATCH TIME: 6 minutes]
Latest:
Future Outlook for Alzheimer’s DiseaseDrs Atri, Cohen, Sabbagh and McDade share their enthusiasm and optimism about the future outlook for Alzheimer’s disease.
Latest:
Connecting ALS: How New Drug Coverage Decisions Are MadeIn this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.
Latest:
Ana Pereira, MD: Repurposing Riluzole for Alzheimer DiseaseThe assistant professor of neurology and neuroscience at Mount Sinai Medical Center detailed the promise marked by the results of a recent pilot trial of riluzole in Alzheimer disease.
Latest:
Refining Alzheimer Treatment Through Biomarker-Based Patient Selection: Michael Woodward, MD, FRACP; Anthony Caggiano, MD, PhDThe head of dementia research at Austin Health and the chief medical officer at Cognition Therapeutics talked about recently presented phase 2 findings on CT1812, an investigational medicine for patients with mild to moderate Alzheimer disease, at CTAD 2024. [WATCH TIME: 5 minutes]
Latest:
CMSC Live: 2025 Annual Meeting Day 3Host Jeffrey Wilken, PhD, chats with Riley Bove, MD, about the third day of the 2025 CMSC Annual Meeting in Phoenix, Arizona.
Latest:
A New Approach to Protein Misfolding in Parkinson DiseasePreviously, many promising treatments for PD have ultimately resulted in untenable adverse effects or in failure, but the evolving area of protein folding offers an opportunity to slow or reverse the neurodegenerative process.
Latest:
Improvements to the Detection, Psychosocial Aspects of Narcolepsy in Adolescents: Eric Zhou, PhDThe assistant professor of pediatrics at Harvard Medical School provided perspective on the care needs of adolescents and young adults with narcolepsy, and the importance of early detection of lingering issues. [WATCH TIME: 3 minutes]
Latest:
Proper Ways to Engage Underserved Populations in Pain Medicine: Burel Goodin, PhDThe professor of anesthesiology at Washington University in St. Louis provided perspective on the respect and approach that comes with conducting research in underserved or impoverished communities. [WATCH TIME: 4 minutes]
Latest:
Incorporation of Biomarkers, Synaptic Plasticity, in Treatment Paradigm for Alzheimer Disease: Alessio Travaglia, PhDThe director at the Foundation for the National Institutes of Health discussed relevant biomarkers for Alzheimer disease and their role as novel therapeutics continue to emerge. [WATCH TIME: 5 minutes]
Latest:
Less Invasive Epilepsy Surgery May Help Turn Candidates Into ConsultsRecent advances in stereoelectroencephalography and laser ablation may help convert those who may be candidates for pediatric epilepsy surgery to those who proceed with a consultation.
Latest:
The Role of Music & Movement in Parkinson Disease TreatmentKenneth Ngo, MD, medical director for the Brain Injury Program at Brooks Rehabilitation’s 3 inpatient hospitals, highlighted how cotreatment between music therapy and physical therapy can significantly improve the overall quality of life for patients with Parkinson disease.
Latest:
Tension-Type Headache, An Understudied and Undertreated Condition: Sait Ashina, MD, FAHSThe assistant professor of neurology at Harvard Medical School talked about the prevalence of tension-type headache and how recent advances shed light on its pathophysiological mechanisms, leading to potential new treatments for the condition. [WATCH TIME: 5 minutes]
Latest:
Evolving Landscape of Pediatric Neurology: Erika Fullwood Augustine, MD, MSThe associate chief science officer at Kennedy Krieger Institute shared thoughts on the state of pediatric neurology and the significance of being named winner of the Sydney Carter Award. [WATCH TIME: 3 minutes]
Latest:
Discontinuing Disease-Modifying Therapies in Multiple Sclerosis: Deborah Miller, PhDThe staff member at the Mellen Center for Multiple Sclerosis discussed reasons why patients may stop treatment, as well as strategies for maintaining communication with the healthcare team in the event of discontinuation. [WATCH TIME: 5 minutes]
Latest:
Incorporating Palliative Care Principles into Movement Disorder Management: Jennifer Corcoran, MDThe movement disorder neurologist at University of Rochester Medical Center outlined a 5-pillar model that emphasized holistic care, patient-centered communication, and proactive support in movement disorders. [WATCH TIME: 5 minutes]
Latest:
Exploring Potential Therapeutic Opportunities for GammaTile in Neurosurgery: Matthew Shepard, MDThe neurosurgeon at Allegheny Health Network discussed the current uses of GammaTile following tumor removal, and the research needed to unlock greater potential. [WATCH TIME: 3 minutes]
Latest:
Creating Positive, Helpful Work Environments for Patients With NMOSD: Farrah Mateen, MD, PhDThe associate director of the Multiple Sclerosis & Neuromyelitis Optica Unit at Massachusetts General Hospital discussed the ways employers and clinicians can alleviate work hardships experienced by patients with NMOSD. [WATCH TIME: 3 minutes]
Latest:
Future Research on Neuronal Microstructure Integrity in Migraine Using High-Gradient Diffusion MRI: Katharina Eikermann-Haerter, MDThe associate professor in the department of radiology at NYU Langone provided perspective on the unanswered questions regarding neuronal microstructure in migraine following her presentation at the 2024 AAN Annual Meeting. [WATCH TIME: 4 minutes]
Latest:
Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MDThe neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]
Latest:
Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MDOutlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]
Latest:
Medical Gaslighting: Multiple Sclerosis’ Dirty Little Secret?The effect of gaslighting on patients can result in serious harms, and although it is potentially common in the MS care continuum, whether it is deliberate or an institutional problem, it must be called out by providers.
Latest:
AUPN Leadership Minute Episode 35: Building a High-Quality QI ProgramEpisode 35 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Carl Gold, MD, MS, of Stanford University. [WATCH TIME: 5 minutes]
Latest:
Acumen Pharmaceuticals’ Phase 2 Advancements in Alzheimer Disease Screening: Todd Feaster, PsyDThe senior clinical research scientist at Acumen Pharmaceuticals talked about the company's approach to refining Alzheimer screening by implementing plasma p-tau 217 biomarkers. [WATCH TIME: 5 minutes]
Latest:
Advice for Advanced Practice Providers in Managing Sleep DisordersAdvanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.
